Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Colgate-Palmolive Company for the period ended March 31, 2000. The company operates globally in Oral, Personal, and Household Care, as well as Pet Nutrition. As of April 30, 2000, there were 576,648,224 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 2000 | Q1 1999 |
|---|---|---|
| Net Sales | $2,241.8 million | $2,175.3 million |
| Gross Profit | $1,221.2 million | $1,165.9 million |
| Gross Margin | 54.5% | 53.6% |
| Net Income | $239.9 million | $208.9 million |
| Diluted EPS | $0.38 | $0.32 |
| Operating Cash Flow | $333.6 million | $322.0 million |
| Cash and Equivalents | $206.4 million | $189.0 million |
| Total Debt (Current + Long-term) | $2,803.7 million | $2,789.5 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 3% year-over-year. This growth was driven by a 7% increase in unit volume, partially offset by unfavorable foreign currency exchange rates. Without currency impacts, sales would have grown 7%.
- Profitability: Net income rose 14.8% to $239.9 million. Diluted earnings per share increased 18.8% to $0.38.
- Margin Expansion: Gross profit margin improved to 54.5% from 53.6% due to manufacturing streamlining and global sourcing. SG&A expenses as a percentage of sales decreased slightly to 36.4%.
- Regional Performance:
- Latin America: Sales up 10% (volume +11%) driven by growth in Mexico, Venezuela, and Colombia.
- Asia/Africa: Sales up 4% (volume +9%) with significant growth in China and India.
- Europe: Sales declined 8% due to the weakened Euro, despite a 3% volume increase.
- North America: Sales up 5% (volume +4%) driven by new product introductions.
- One-Time Items: The company incurred $18.7 million in one-time restructuring charges (manufacturing consolidation and asset write-downs in Africa), which were almost entirely offset by a one-time gain on the sale of real estate.
Guidance, Outlook, and Risks
- Outlook: Management notes that interim results may not be representative of full-year results. The effective tax rate for Q1 2000 was 34.0%, reflecting the current estimate for the full year, which is slightly higher than the 1999 full-year rate of 32.8%.
- Liquidity: Net cash provided by operating activities increased to $333.6 million. The company maintains $520.6 million in commercial paper classified as long-term debt based on intent to refinance.
- Capital Allocation: Significant cash was used for financing activities, including $239.9 million for the purchase of common stock and $91.8 million for dividends paid.
- Risks: The filing highlights the impact of foreign currency fluctuations (e.g., Euro weakness, Brazilian Real devaluation in prior year) on reported sales and comprehensive income. Legal proceedings are referenced in the 1999 10-K but no new material litigation is detailed in this summary.
Investor Verification Checklist
- Verify the sustainability of the 7% unit volume growth across all regions, particularly in Latin America and Asia/Africa.
- Monitor the impact of foreign exchange rates on future earnings, given the significant offset to sales growth in Q1 2000.
- Review the details of the $18.7 million restructuring charges and the corresponding real estate gain to ensure they are truly non-recurring.
- Assess the company's debt refinancing strategy, specifically regarding the $520.6 million in commercial paper classified as long-term.
- Confirm the full-year effective tax rate projection of 34.0% against actual year-end results.